United States
Germany
Japan
United Kingdom
China
Transient overexpression lysate of spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 1
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Products
SPG20 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
SPG20 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
SPG20 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 3
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 4
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of spastic paraplegia 20 (Troyer syndrome) (SPG20), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Rabbit Polyclonal Anti-SPG20 Antibody
| Applications | WB |
| Reactivities | Human |
SPART Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
SPG20 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
